2026 NPPES data Hematology & Oncology Physician NPI 1588191662 MD
Verify on CMS →

MICHAIL ALEVIZAKOS, MD

Hematology & Oncology Physician in CHESAPEAKE, Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
160
Medicare Part D claims · 45 beneficiaries · Hematology & Oncology Physician avg: 847
MIPS score
94.0775/100
▲ 11 pts above national avg 83.1 · [object Object]
Industry payments
$297.8
9 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MICHAIL ALEVIZAKOS, MD is a Hematology & Oncology Physician ([object Object]) practicing in CHESAPEAKE, Virginia with a Medicare Part D prescribing footprint of 160 claims across 45 beneficiaries . Their CMS MIPS Final Score of 94.0775/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $297.8 across 9 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MICHAIL ALEVIZAKOS, MD reported a CMS MIPS final score of 94.0775 out of 100, above the 83.1 national average, and filed 160 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MICHAIL ALEVIZAKOS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MICHAIL ALEVIZAKOS, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 05/19/2017

NPI 1588191662

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

160 81% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

94.0775/100 10.977500000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Virginia

How Hematology & Oncology Physician compares to other specialties among Virginia providers

Virginia providers

Hematology & Oncology Physician share within Virginia

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Virginia

Medicare quality performance — MIPS

MICHAIL ALEVIZAKOS, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
94.0775/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 94.0775/100 vs national avg 83.1

0%100%National avg83%94.1%
MIPS final score (Hematology & Oncology Physician) — 94.0775/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAIL ALEVIZAKOS, MD is a Hematology & Oncology Physician provider practicing in CHESAPEAKE, Virginia, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1588191662. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAIL ALEVIZAKOS, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 110 WIMBLEDON SQ STE E, CHESAPEAKE, VA, 23320, with a listed phone of (757) 436-2995. NPI 1588191662 was issued on 05/19/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALEVIZAKOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 160 prescription claims written by this provider, covering 45 Medicare beneficiaries and totaling roughly $312K in drug spend, with an opioid prescribing rate of 11.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.0775/100 for the 2023 performance year (Quality 90.6515), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

110 WIMBLEDON SQ STE E
CHESAPEAKE, VA 23320

Provider Details

NPI 1588191662
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 05/19/2017

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.0775
Final Score
Avg: 83.1
90.6515
Quality
95.8391
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MICHAIL ALEVIZAKOS, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PENINSULA CANCER INSTITUTE, LLC
CHESAPEAKE, VA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAIL ALEVIZAKOS, MD. Source: openpaymentsdata.cms.gov.

Total received

$298

Largest payer

Merck Sharp & Dohme LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

160
Total Claims
$312K
Total Drug Cost
45
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
241
Total Day Supply
6,371
Generic Drug Cost
$11K
Opioid Claims
18 (11.3% rate)

Patient Demographics

Average Patient Age
70.1 years
Avg HCC Risk Score
2.74
Gender Split
53% female / 47% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
19
Hydroxyurea
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MICHAIL ALEVIZAKOS, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MICHAIL ALEVIZAKOS, MD's 160 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Virginia

Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as ALEVIZAKOS.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAIL ALEVIZAKOS, MD's specialty?
MICHAIL ALEVIZAKOS, MD specializes in Hematology & Oncology Physician and practices in CHESAPEAKE, Virginia. Credentials: MD.
How much does MICHAIL ALEVIZAKOS, MD prescribe under Medicare Part D?
In 2023, MICHAIL ALEVIZAKOS, MD wrote 160 Medicare Part D claims totaling $312K in drug costs for 45 beneficiaries.
What is MICHAIL ALEVIZAKOS, MD's Medicare quality score?
MICHAIL ALEVIZAKOS, MD has a CMS MIPS Final Score of 94.0775/100 (Quality: 90.6515). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAIL ALEVIZAKOS, MD located?
MICHAIL ALEVIZAKOS, MD is located at 110 WIMBLEDON SQ STE E, CHESAPEAKE, VA, 23320. Phone: (757) 436-2995.
What is MICHAIL ALEVIZAKOS, MD's NPI number?
MICHAIL ALEVIZAKOS, MD's National Provider Identifier (NPI) is 1588191662, issued on 05/19/2017.
Does MICHAIL ALEVIZAKOS, MD prescribe opioids?
Yes, MICHAIL ALEVIZAKOS, MD had 18 opioid claims in 2023 with an opioid prescribing rate of 11.3%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MICHAIL ALEVIZAKOS, MD prescribe most often?
Based on 2023 Medicare Part D data, MICHAIL ALEVIZAKOS, MD's most frequently prescribed drugs include Anastrozole, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAIL ALEVIZAKOS, MD accept Medicare?
MICHAIL ALEVIZAKOS, MD appears in CMS Medicare data with 160 Part D claims and 45 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAIL ALEVIZAKOS, MD's credentials?
MICHAIL ALEVIZAKOS, MD's NPI is 1588191662 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology